What are the potential drug interactions with Linzess (linaclotide)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Drug Interactions of Linzess (Linaclotide)

Linzess (linaclotide) has minimal drug interactions due to its negligible systemic absorption and local action in the gastrointestinal tract. 1

Pharmacokinetic Profile and Interaction Potential

Linaclotide has pharmacokinetic properties that make drug interactions unlikely:

  • Minimal absorption: Linaclotide is minimally absorbed with negligible systemic availability following oral administration 1
  • Local action: It works locally on the luminal surface of the intestinal epithelium 1
  • Undetectable plasma levels: Concentrations of linaclotide and its active metabolite in plasma are below the limit of quantitation after oral administration of therapeutic doses 1
  • Gastrointestinal metabolism: Linaclotide is metabolized within the gastrointestinal tract to its principal active metabolite by loss of the terminal tyrosine moiety 1

Confirmed Lack of Drug Interactions

The FDA label specifically states:

  • No drug-drug interaction studies have been conducted with LINZESS due to negligible systemic exposure following oral administration 1
  • Linaclotide does not interact with the cytochrome P450 enzyme system based on in vitro studies 1
  • Linaclotide does not interact with common efflux and uptake transporters (including P-glycoprotein) 1
  • Based on these data, no drug-drug interactions through modulation of CYP enzymes or common transporters are anticipated 1

Food Interactions

While not a drug interaction, food intake affects Linzess efficacy:

  • Taking LINZESS immediately after a high-fat breakfast results in looser stools and higher stool frequency compared to taking it in the fasted state 1
  • In clinical trials, LINZESS was administered on an empty stomach, at least 30 minutes before a meal 1

Safe Combination with Other Constipation Treatments

  • Linaclotide can be safely taken with other constipation treatments like senna, as they work through different mechanisms 2
  • Both medications are listed as options for treating constipation in treatment algorithms without contraindications for combined use 2

Practical Considerations

  • Administration timing: Take Linzess on an empty stomach, at least 30 minutes before the first meal of the day 1
  • Monitoring: When using Linzess with other medications for constipation, monitor for excessive diarrhea and signs of dehydration, particularly in elderly patients 2
  • Caution in specific populations: Use with caution in elderly patients who may be more susceptible to diarrhea-induced dehydration 2

Common Pitfalls to Avoid

  1. Administering with food: Taking Linzess with food significantly reduces its efficacy
  2. Overlooking dehydration risk: While not a drug interaction, the most common side effect of Linzess is diarrhea (occurring in 16-20% of patients), which could potentially lead to dehydration, especially in vulnerable populations 2
  3. Assuming systemic interactions: Unlike many medications, Linzess works locally in the gut with minimal systemic absorption, so traditional drug interaction concerns are not applicable

In summary, Linzess has a favorable drug interaction profile due to its minimal systemic absorption and local mechanism of action in the gastrointestinal tract.

References

Guideline

Constipation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.